Active Ingredient History
CO or variants may refer to: Wikipedia
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Anemia, Sickle Cell (Phase 1)
Carbon Monoxide (Phase 1/Phase 2)
Endothelial Cells (Phase 1)
Healthy Volunteers (Phase 1)
Heart Diseases (Phase 1/Phase 2)
Hypertension, Pulmonary (Phase 1/Phase 2)
Idiopathic Pulmonary Fibrosis (Phase 2)
Ileus (Phase 2)
Kidney Transplantation (Phase 2)
Organelle Biogenesis (Phase 1/Phase 2)
Pulmonary Diffusing Capacity (Phase 1)
Pulmonary Disease, Chronic Obstructive (Phase 2)
Respiratory Distress Syndrome (Phase 2)
Sepsis (Phase 1)
Smoking (Phase 1)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue